Cellular changes in denervated tissue during wound healing in a rat model

British Journal of Dermatology

Volumn 140, Issue 6, 1999, Pages 1093-1099

  Richards, A M ^a,c   Floyd, D C ^a   Terenghi, G ^b   McGrouther, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN VICTORIA HOSPITAL   (United Kingdom)

^c SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Denervation; Macrophages; Neuropeptides; T lymphocytes; Wound healing

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DENERVATION; FEMALE; INFLAMMATORY CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; B-LYMPHOCYTES; CALCITONIN GENE-RELATED PEPTIDE; DENERVATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MACROPHAGES; MONOCYTES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURGICAL FLAPS; T-LYMPHOCYTES; THIOLESTER HYDROLASES; TIME FACTORS; UBIQUITIN THIOLESTERASE; WOUND HEALING;

EID: 0032983449     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02908.x     Document Type: Article

References (39)

1. 1 Whitby DJ, Ferguson MWJ. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147: 201-15.
2. 2 Shah M, Foreman DM, Ferguson MWJ. Neutralising antibody to TGF-β reduces cutaneous scarring in adult rodents. J Cell Sci 1994; 107: 1137-57.
3. 3 Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002.
4. 4 Clarke RAF. Overview and general considerations of wound repair. In: The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1988: pp. 3-33.
5. 5 Gruschwitz M. Muller PU, Sepp M et al. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990; 94: 197-203.
6. 6 Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by anti-serum against growth factor β1. Nature 1990; 346: 371-4.
7. 7 Broekelmann TJ. Limper AH, Colby TV, McDonald JA. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Nat Acad Sci USA 1991; 88: 6642-6.
8. 8 Castilla A, Prieto J, Fausto N. Transforming growth factor β and α in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991; 324: 933-40.
9. 9 Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor β on post-operative adhesion formation and intact peritoneum. J Surg Res 1992; 52: 65-70.
10. 10 McGillis JP, Organist ML, Payan DG. Substance P and immuno-regulation. Fed Proc 1987; 46: 196-9.
11. 11 Perianin A, Snyderman R, Malfroy B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun 1989; 161: 520-4.
12. 12 Tomoe S, Iwamoto I, Yoshida S et al. The potencies of substance P. substance P fragments, and compound 48/80 for granulocyte infiltration in mouse skin. Arerugi 1992; 41: 119-24.
13. 13 Piotrowski W, Devoy MAB, Jordan CC, Foreman JC. The substance P receptor on rat mast cells and in human skin. Agents Actions 1984; 14: 420-4.
14. 14 Pascual DW, Blalock JE, Bost KL, Antipeptide antibodies that recognise a lymphocyte substance P receptor. J Immunol 1989; 143; 3697-702.
15. 15 Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and histamine release. Br J Dermatol 1986; 114: 37-46.
16. 16 Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochem Biophys Res Commun 1998; 154: 227.
17. 17 Cappugi P, Gerini G, Verrone C et al. Esperienze preliminare sull'attivita chemiotattica del CGRP con lo skin window test. G Ital Dermatol Venereol 1990; 125: 135-8.
18. 18 Li AKC, Koroly MJ, Schattenkerk ME et al. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci USA 1980; 77: 4379-81.
19. 19 Lawman MJ, Boyle MDP, Gee AP, Young M. Nerve growth factor accelerates the early cellular events associated with wound healing. Exp Mol Pathol 1985; 43: 274-81.
20. 20 Pecoraro RE. Ahroni J, Boyko E, Stensel V. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991; 40: 1305-13.
21. 21 Karanth SS, Springall DR, Lucas S et al. Changes in nerves and neuropeptides in skin from 100 leprosy patients investigated by immunohistochemistry. J Pathol 1989; 157: 15-26.
22. 22 Carr RW, Delaney CA, Westerman RA, Roberts RG. Denervation impairs cutaneous microvascular function and blister healing in the rat hindlimb. NeuroReport 1993; 4: 467-70.
23. 23 Araki K, Ohashi Y, Kinoshita S et al. Epithelial wound healing in the denervated cornea. Curr Eye Res 1994; 13: 203-11.
24. 24 Parkhouse N, Crowe R, McGrouther DA, Burnstock G. Painful hypertrophic scarring and neuropeptides. (Letter.) Lancet 1992; 340: 1410.
25. 25 Richards A, Mitsou J. Floyd D et al. Neural innervation and healing (letter). Lancet 1997; 350: 339-40.
26. 26 Nishikawa H, Manek S, Green CJ. The oblique rat groin flap. Br J Plast Surg 1991; 44: 295-8.
27. 27 Manek S, Terenghi G, Shurey C et al. Neovascularisation precedes neural changes in the rat groin skin flap following denervation: an immunohistochemical study. Br J Plast. Surg 1993; 46: 48-55.
28. 28 Crowe R, Mitsou J, McGrouther DA, Burnstock G. An increase in the growth of hair associated with hyperinnervation of the underlying vessels in rabbit skin. Neurosci Lett 1993; 161: 105-8.
29. 29 McGrath MH. Peptide growth factors and wound healing. Clin Plast Surg 1990; 17: 421-32.
30. 30 McKay IA, Leigh IM. Epidermal cytokines and their role in cutaneous wound healing. Br J Dermatol 1991; 124: 513-18.
31. 31 Ross R, Raines EW. Platelet-derived growth factor and cell proliferation. In: Growth Factors: from Genes to Clinical Application. New York: Raven Press, 1990: 193-9.
32. 32 Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH, Stimulation of chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987; 165: 251-6.
33. 33 Gabbiani G. The biology of the myofibroblast. Kidney Int 1992: 41: 530-2.
34. 34 Welch MP, Odland GF, Clark RAF. Temporal relationship of f-actin bundle formation, collagen and fibronectin matrix assembly and fibronectin receptor expression to wound contraction. J Cell Biol 1990; 110: 133-45.
35. 35 Hartung HP, Toyka KV. Activation of macrophages by substance P. Induction of oxidative burst and thromboxane release. Eur J Pharmacol 1983; 89: 301-5.
36. 36 Jesseph J, Felten D. Noradrenergic innervation of the gut associated lymphoid tissue in the rabbit. Anat Rec 1984; 208: 204-9.
37. 37 Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ. Substance P recognition by a subset of human T lymphocytes. J Clin Invest 1984; 74: 1532-9.
38. 38 Sreedharan SP, Kodama KT, Peterson K, Goetzl EJ. Distinct subsets of somatostatin receptors on cultures human lymphocytes. J Biol Chem 1989; 264: 949-52.
39. 39 Skalli O, Propaz P, Trzeciak A et al. A monoclonal antibody against a-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787-96.